View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/CMS RIN: 0938-AU66 Publication ID: Spring 2021 
Title: ●Requirements Related to Prescription Drug Reporting (CMS-9905) 
Abstract:

This notice would request information to inform the development of rulemaking that would implement the prescription drug reporting requirements that apply to group health plans and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act of 2021

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Prerule Stage 
Major: Undetermined  Unfunded Mandates: Undetermined 
CFR Citation: Not Yet Determined     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: Pub. L. 116-260, Division BB, title I and title II   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Request for Information  05/00/2021 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Local, State 
Small Entities Affected: No  Federalism: Yes 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Related Agencies: Joint: DOL/EBSA, TREAS/IRS; 
Agency Contact:
Christina Whitefield
Director, Medical Loss Ratio Division
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Consumer Information and Insurance Oversight, MS: 733H.02, 7500 Security Blvd,
Baltimore, MD 21244
Phone:301 492-4172
Email: christina.whitefield@cms.hhs.gov